FMC - Madison is a medicare approved dialysis facility center in Madison, Indiana and it has 12 dialysis stations. It is located in Jefferson county at 1708 Cragmont Street, Madison, IN, 47250. You can reach out to the office of FMC - Madison at (812) 273-7132. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC - Madison has the following ownership type - Profit. It was first certified by medicare in February, 2005. The medicare id for this facility is 152590 and it accepts patients under medicare ESRD program.
| Name | FMC - Madison |
|---|---|
| Location | 1708 Cragmont Street, Madison, Indiana |
| No. of Dialysis Stations | 12 |
| Medicare ID | 152590 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 1708 Cragmont Street, Madison, Indiana, 47250 | |
| (812) 273-7132 | |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago
| NPI Number | 1396762035 |
| Organization Name | Fresenius Medical Care Of Madison |
| Doing Business As | Bio-medical Applications Of Indiana, Inc. |
| Address | 1708 Cragmont St Madison, Indiana, 47250 |
| Phone Number | (812) 273-7131 |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago
| Dialysis patients with Hemoglobin data | 22 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 14 |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 27 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 256 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
| Percentage of pediatric patients getting regular hemodialysis at the center |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC - Madison with elevated calcium levels.
| Patients with hypercalcemia | 30 |
| Hypercalcemia patient months | 279 |
| Patients with Serumphosphor | 35 |
| Patients with Serumphosphor less than 3.5 mg/dL | 12 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 22 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 27 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 32 |
| Patients with Serumphosphor greater than 7 mg/dL | 7 |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 33 |
| Patient months included in arterial venous fistula and catheter summaries | 280 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 77 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 11 |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 28 |
| Hospitalization Rate in facility | 127.1 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 280.5 |
| Hospitalization Rate: Lower Confidence Limit | 61.3 |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC - Madison were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 11.8 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 26.7 |
| Readmission Rate: Lower Confidence Limit | 3.5 |
News Archive
The Philippines' Department of Health (DOH) on Friday - in partnership with UNICEF, the U.N. Population Fund (UNFPA), the WHO and the Australian Agency for International Development (AusAID) - launched a seven-year program aimed at reducing maternal and infant mortality rates, the Philippine Star reports.
Oxygen Biotherapeutics, Inc. announced today that its common stock has been approved for secondary listing on the SIX Swiss Exchange in addition to its listing on the NASDAQ Capital Market. Bank am Bellevue of Zurich is acting as the company's listing agent.
Flagship Ventures, a leading innovation and venture firm focused on healthcare and sustainability, announced it has launched Rubius Therapeutics, to develop functionalized red blood cells for the treatment of autoimmune conditions, metabolic diseases, cancer, and other serious diseases.
New research published in the July edition of the Journal of Nutritional Biochemistry, has established a strong correlation between blood levels of omega-3s, especially docosahexaenoic acid (DHA), and better brain function in children two to six years old.
› Verified 8 days ago